Robinson E S J, Price R E, Nutt D J, Hudson A L
Psychopharmacology Unit, School of Medical Sciences, Bristol BS8 1TD, UK.
Ann N Y Acad Sci. 2003 Dec;1009:283-7. doi: 10.1196/annals.1304.037.
BU98008 (1-(4, 5-dihydro-1H-imidazol-2-yl)isoquinoline) is a novel isoquinoline derivative. Radioligand binding studies revealed it had high affinity for the I(1) receptor in rat kidney membranes but low affinity for the I(2) binding site and alpha(2)-adrenoceptor in rat brain membranes. Further evaluation of BU98008 in vivo revealed no effect on blood pressure following peripheral administration. These preliminary data suggest BU98008 may be an antagonist at I(1) receptors. Further evaluation following central administration must be performed before a hypotensive action can be excluded.
BU98008(1-(4,5-二氢-1H-咪唑-2-基)异喹啉)是一种新型异喹啉衍生物。放射性配体结合研究表明,它对大鼠肾膜中的I(1)受体具有高亲和力,但对大鼠脑膜中的I(2)结合位点和α(2)-肾上腺素能受体具有低亲和力。对BU98008进行的进一步体内评估显示,外周给药后对血压无影响。这些初步数据表明,BU98008可能是I(1)受体的拮抗剂。在排除降压作用之前,必须进行中枢给药后的进一步评估。